A detailed history of Verition Fund Management LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 21,147 shares of HROW stock, worth $774,826. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,147
Holding current value
$774,826
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$20.85 - $46.47 $440,914 - $982,701
21,147 New
21,147 $950,000
Q1 2023

May 15, 2023

BUY
$13.84 - $21.46 $366,939 - $568,968
26,513 New
26,513 $561,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $992M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.